Commentary on "Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease." Biochemical biomarkers of late-life dementia

Alzheimers Dement. 2006 Oct;2(4):287-93. doi: 10.1016/j.jalz.2006.05.2347.
No abstract available

Publication types

  • Comment